注册 | 登录
点击这里给我发消息
所有产品
  • 所有产品
  • 一抗
  • 裂解液
>   首页   >   产品   >   B7-H3 (4Ig) /B7-H3b   

B7-H3 (4Ig) /B7-H3b

     
  • 产品详情
  • 实验流程
Product Information
Primary Accession Q5ZPR3-1
Species Human
Sequence Gly27-Thr461
Purity > 95% as determined by Bis-Tris PAGE
> 95% as determined by HPLC
Endotoxin Level Less than 1EU per µg by the LAL method.
Biological Activity Immobilized B7-H3 (4Ig) /B7-H3b hFc Chimera[FITC], Human (Cat.No.: Z03891) at 1 µg/ml (100 µl/Well) on the plate can bind Biotinylated Anti-B7-H3 Antibody, hFc Tag
Expression System HEK293
Theoretical Molecular Weight 73.4 kDa
Formulation Lyophilized from a 0.22 µm filtered solution in PBS, pH 7.4.
Reconstitution It is recommended that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute the lyophilized powder in ddH2O more than 100 µg/ml.
Storage & Stability Upon receiving, the product remains stable up to 6 months at -20 °C or below. Upon reconstitution, the product should be stable for 3 months at -80 °C. Avoid repeated freeze-thaw cycles.
Additional Information
Target Background B7-H3, a member of the B7 family of immunomodulatory molecules, is overexpressed in a wide range of solid cancers.B7-H3 binds to activated T cells via an as yet unidentified receptor. In assays using sub-optimal amount so anti-CD3 stimulation, 2Ig‑B7‑H3 enhances T cell proliferation, T cell interferon-gamma (IFN-gamma) production, and cytotoxic T cells induction.
Protein Information
Research Areas

For Research Use Only. Not For Use In Diagnostic Procedures.

FeedBack

终于等到您。ABCEPTA(百远生物)抗体产品。
点击下方“我要评价 ”按钮提交您的反馈信息,您的反馈和评价是我们最宝贵的财富之一,
我们将在1-3个工作日内处理您的反馈信息。

如有疑问,联系:0512-88856768 tech-china@abcepta.com.


我要评价